ArticleOncology letters2025

Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapy.

Abdurrahman Alp Tokalioglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.